REGN3918
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for REGN3918, covering 2023-06-12 to 2023-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]